Regulatory13 Apr 2026, 03:24 pm
Ishita Drugs: SEBI Reg 32(1) on fund utilization not applicable for FY26
AI Summary
Ishita Drugs & Industries Ltd confirmed that Regulation 32(1) of SEBI (LODR) Regulations, 2015, concerning the Statement of Deviation or Variation from fund proceeds, is not applicable for the financial year ended March 31, 2026. The company did not raise any funds through public issue, rights issue, preferential issue, or QIP during FY26, thus negating the requirement to submit such a statement.
Key Highlights
- SEBI Regulation 32(1) is not applicable to the company.
- No fund deviation or variation statement required for FY26.
- Company raised no funds via public, rights, preferential, or QIP issues.
Price Impact
More from ISHITADR
More in Regulatory